Interferon alpha--a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity.

[1]  Man-Fung Yuen,et al.  Viral hepatitis B , 2003, The Lancet.

[2]  D. Sylvestre,et al.  Vogt‐Koyanagi‐Harada disease associated with interferon alpha‐2b/ribavirin combination therapy , 2003, Journal of viral hepatitis.

[3]  E. Bonifacio,et al.  Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. , 2003, JAMA.

[4]  Y. Shoenfeld,et al.  Autoimmune aspects of cytokine and anticytokine therapies. , 2003, The American journal of medicine.

[5]  M. Rewers,et al.  Timing of initial cereal exposure in infancy and risk of islet autoimmunity. , 2003, JAMA.

[6]  D Vergani,et al.  Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy , 2003, Alimentary pharmacology & therapeutics.

[7]  M. Höglund,et al.  Pulmonary side effects of interferon‐α therapy in patients with hematological malignancies , 2003 .

[8]  T. Stewart.  Neutralizing interferon alpha as a therapeutic approach to autoimmune diseases. , 2003, Cytokine & growth factor reviews.

[9]  M. Requena,et al.  High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon‐α , 2003, American journal of hematology.

[10]  S. Brod.  Ingested type I interferon: a potential treatment for autoimmunity. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[11]  Terri H Lipman,et al.  The epidemiology of type 1 diabetes in children in Philadelphia 1990-1994: evidence of an epidemic. , 2002, Diabetes care.

[12]  H. Hyöty,et al.  The role of viruses in human diabetes , 2002, Diabetologia.

[13]  J. Bach,et al.  The effect of infections on susceptibility to autoimmune and allergic diseases. , 2002, The New England journal of medicine.

[14]  S. Taki.  Type I interferons and autoimmunity: lessons from the clinic and from IRF-2-deficient mice. , 2002, Cytokine & growth factor reviews.

[15]  T. Tuvemo,et al.  Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset. , 2002, Diabetes.

[16]  L. Wen,et al.  Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[17]  N. Sarvetnick,et al.  Target cell defense prevents the development of diabetes after viral infection , 2002, Nature Immunology.

[18]  E. Jaeckel,et al.  Viruses and Diabetes , 2002, Annals of the New York Academy of Sciences.

[19]  E. Gale,et al.  A missing link in the hygiene hypothesis? , 2002, Diabetologia.

[20]  M. Atkinson,et al.  Ingested IFN-alpha preserves residual beta cell function in type 1 diabetes. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[21]  Virginia Pascual,et al.  Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus , 2001, Science.

[22]  A. Hämäläinen,et al.  The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study. , 2001, The Journal of clinical endocrinology and metabolism.

[23]  M. Atkinson,et al.  Type 1 diabetes: new perspectives on disease pathogenesis and treatment , 2001, The Lancet.

[24]  H. Jun,et al.  The role of viruses in Type I diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals , 2001, Diabetologia.

[25]  B. Blom,et al.  Generation of Interferon α–Producing Predendritic Cell (Pre-Dc)2 from Human Cd34+ Hematopoietic Stem Cells , 2000, The Journal of experimental medicine.

[26]  F. Pattou,et al.  Persistent Infection of Human Pancreatic Islets by Coxsackievirus B Is Associated with Alpha Interferon Synthesis in β Cells , 2000, Journal of Virology.

[27]  M. Knip,et al.  Neonatal Type I diabetes associated with maternal echovirus 6 infection: a case report , 2000, Diabetologia.

[28]  J. Ilonen,et al.  T-cell responses to enterovirus antigens in children with type 1 diabetes. , 2000, Diabetes.

[29]  K. Kyvik,et al.  The antiviral 2',5'-oligoadenylate synthetase is persistently activated in type 1 diabetes. , 2000, Clinical immunology.

[30]  J. Weill,et al.  Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection. , 2000, The Journal of infectious diseases.

[31]  P. McKinney,et al.  Rising incidence of childhood diabetes is seen at all ages and in urban and rural settings in Yorkshire, United Kingdom , 2000, Diabetologia.

[32]  J. Ilonen,et al.  Disease-associated autoantibodies as surrogate markers of type 1 diabetes in young children at increased genetic risk. Childhood Diabetes in Finland Study Group. , 2000, The Journal of clinical endocrinology and metabolism.

[33]  R. Inman,et al.  Molecular mimicry and autoimmunity. , 1999, The New England journal of medicine.

[34]  J. Tuomilehto,et al.  Worldwide increase in incidence of Type I diabetes – the analysis of the data on published incidence trends , 1999, Diabetologia.

[35]  N. Kadowaki,et al.  The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.

[36]  A. Ziegler,et al.  Early expression and high prevalence of islet autoantibodies for DR3/4 heterozygous and DR4/4 homozygous offspring of parents with Type I diabetes: The German BABYDIAB study , 1999, Diabetologia.

[37]  S. Garg,et al.  Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study , 1999, BMJ.

[38]  S. Darcan,et al.  Ingested interferon α suppresses Type I diabetes in non-obese diabetic mice , 1998, Diabetologia.

[39]  G. Clements,et al.  Simultaneous onset of Type 1 diabetes mellitus in identical infant twins with enterovirus infection , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[40]  G. Asins,et al.  Evidence from Transgenic Mice That Interferon-β May Be Involved in the Onset of Diabetes Mellitus* , 1998, The Journal of Biological Chemistry.

[41]  A. Pezzoli,et al.  Gastric autoimmune disorders in patients with chronic hepatitis C before, during and after interferon-alpha therapy. , 1998, World journal of gastroenterology.

[42]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[43]  M. Matsuhisa,et al.  Interferon induces insulin resistance in patients with chronic active hepatitis C. , 1998, Journal of hepatology.

[44]  J. Donckier,et al.  Diabetes Mellitus and Interferon Therapy , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[45]  T. Okanoue,et al.  Side effects of high-dose interferon therapy for chronic hepatitis C. , 1996, Journal of hepatology.

[46]  T. Stewart,et al.  IFN-alpha induces autoimmune T cells through the induction of intracellular adhesion molecule-1 and B7.2. , 1996, Journal of immunology.

[47]  H. Chase,et al.  Prediction of Type I Diabetes in First-Degree Relatives Using a Combination of Insulin, GAD, and ICA512bdc/IA-2 Autoantibodies , 1996, Diabetes.

[48]  T. Dyrberg,et al.  Differential Responsiveness to Interferon-α in β-Cells and Non-β-Cells , 1996, Diabetes.

[49]  M. Tymms,et al.  A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[50]  G. Dahlquist,et al.  Indications that maternal coxsackie B virus infection during pregnancy is a risk factor for childhood-onset IDDM , 1995, Diabetologia.

[51]  Å. Lernmark,et al.  Interferon Expression in the Pancreases of Patients With Type I Diabetes , 1995, Diabetes.

[52]  M. Knip,et al.  A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. , 1995 .

[53]  M. Knip,et al.  A Prospective Study of the Role of Coxsackie B and Other Enterovirus Infections in the Pathogenesis of IDDM , 1995, Diabetes.

[54]  M. Colombo,et al.  Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. , 1995, European journal of endocrinology.

[55]  Y. Kang,et al.  Complete nucleotide sequence of a strain of coxsackie B4 virus of human origin that induces diabetes in mice and its comparison with nondiabetogenic coxsackie B4 JBV strain , 1994, Journal of medical virology.

[56]  M. A. Bowman,et al.  Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. , 1994, The Journal of clinical investigation.

[57]  Pamela Dockstader,et al.  Antibodies to Glutamic Acid Decarboxylase and P2-C Peptides in Sera From Coxsackie Virus B4-Infected Mice and IDDM Patients , 1994, Diabetes.

[58]  N. Dybdal,et al.  Islet expression of interferon-alpha precedes diabetes in both the BB rat and streptozotocin-treated mice. , 1994, Immunity.

[59]  W. Scherbaum,et al.  Sequence homology of the diabetes-associated autoantigen glutamate decarboxylase with coxsackie B4-2C protein and heat shock protein 60 mediates no molecular mimicry of autoantibodies , 1994, The Journal of experimental medicine.

[60]  A. Ariza,et al.  Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. , 1994, Journal of immunology.

[61]  S. Bohlander,et al.  Nomenclature of the Human Interferon Genesa , 1994 .

[62]  D. Eizirik,et al.  TNF-α and IFN-γ potentiate the deleterious effects of IL-1β on mouse pancreatic islets mainly via generation of nitric oxide , 1994 .

[63]  J. Almond,et al.  Complete nucleotide sequence of a beta‐cell tropic variant of coxsackievirus B4 , 1994, Journal of medical virology.

[64]  A. Rosen,et al.  Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes , 1994, The Journal of experimental medicine.

[65]  Xiaojian Huang,et al.  Induction of type I diabetes by interferon-alpha in transgenic mice. , 1993, Science.

[66]  A. Floreani,et al.  Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis , 1992, The Lancet.

[67]  J. Bellanti,et al.  Poly I:C Induces Development of Diabetes Mellitus in BB Rat , 1992, Diabetes.

[68]  X. Freixas,et al.  Incidence of Type 1 (insulin-dependent) diabetes mellitus in Catalonia, Spain , 1992, Diabetologia.

[69]  B. Boucher,et al.  The Production of Immunoreactive α‐and γ‐Interferon by Circulating Mononuclear Cells in Type 1 Diabetes , 1991 .

[70]  G. Soldevila.  Cytotoxic effect of IFN-? plus TNF-a on human islet cells , 1991 .

[71]  Secular Trends in Incidence of Childhood IDDM in 10 Countries , 1990, Diabetes.

[72]  K. Hamaguchi,et al.  Immunostimulation circumvents diabetes in NOD/Lt mice. , 1989, Journal of autoimmunity.

[73]  K. Cantell,et al.  Effect of Interferon on Glucose Tolerance and Insulin Sensitivity , 1989, Diabetes.

[74]  P. Bingley,et al.  Incidence of insulin dependent diabetes in England: a study in the Oxford region, 1985-6. , 1989, BMJ.

[75]  A. Meager,et al.  IMMUNOREACTIVE α-INTERFERON IN INSULIN-SECRETING β CELLS IN TYPE 1 DIABETES MELLITUS , 1987, The Lancet.

[76]  R. Hardman,et al.  Aberrant expression of Class II major histocompatibility complex molecules by B cells and hyperexpression of Class I major histocompatibility complex molecules by insulin containing islets in Type 1 (insulin-dependent) diabetes mellitus , 1987, Diabetologia.

[77]  M. Shimizu,et al.  Inhibitory effect of interferon on the production of insulin. , 1985, Endocrinology.

[78]  C. Rhodes,et al.  Effect of human lymphoblastoid interferon on insulin synthesis and secretion in isolated human pancreatic islets , 1984, Diabetologia.

[79]  S. Yagihashi,et al.  Congenital rubella syndrome as a model for Type 1 (insulin-dependent) diabetes mellitus: increased prevalence of islet cell surface antibodies , 1984, Diabetologia.

[80]  W. Phillips,et al.  SIMULTANEOUS ONSET OF INSULIN DEPENDENT DIABETES MELLITUS IN SIBLINGS , 1981, The Lancet.

[81]  D. Samolyk,et al.  DIABETES AND COXSACKIE VIRUS B5 INFECTION , 1980, The Lancet.

[82]  A. Notkins,et al.  Immune interferon in the circulation of patients with autoimmune disease. , 1979, The New England journal of medicine.

[83]  T. Onodera,et al.  Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. , 1979, The New England journal of medicine.

[84]  D. R. Gamble,et al.  Familial juvenile-onset diabetes. , 1977, British medical journal.

[85]  D. R. Gamble,et al.  Viral Antibodies in Diabetes Mellitus , 1969, British medical journal.

[86]  K. Hu.  Juvenile diabetes as a sequel to mumps. , 1947 .

[87]  H. Harris.  A Case of Diabetes Mellitus Quickly Following Mumps , 1899 .

[88]  M. Rewers,et al.  Prospective study of enteroviral infections and development of beta-cell autoimmunity. Diabetes autoimmunity study in the young (DAISY). , 2003, Diabetes research and clinical practice.

[89]  H. Jun,et al.  A new look at viruses in type 1 diabetes. , 2003, Diabetes/metabolism research and reviews.

[90]  M. Höglund,et al.  Pulmonary side effects of interferon-alpha therapy in patients with hematological malignancies. , 2003, American journal of hematology.

[91]  G. Trinchieri,et al.  Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. , 2002, The Journal of experimental medicine.

[92]  T. Taniguchi,et al.  IRF family of transcription factors as regulators of host defense. , 2001, Annual review of immunology.

[93]  V. Pascual,et al.  Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. , 2001, Science.

[94]  E. Bonifacio,et al.  Islet cell and thyroid antibody prevalence in patients with hepatitis C virus infection: effect of treatment with interferon. , 2001, The Journal of laboratory and clinical medicine.

[95]  S. Darcan,et al.  Ingested interferon alpha suppresses type I diabetes in non-obese diabetic mice. , 1998, Diabetologia.

[96]  T. Dyrberg,et al.  Differential responsiveness to interferon-alpha in beta-cells and non-beta cells. , 1996, Diabetes.

[97]  G. Fattovich,et al.  A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon. , 1996, Journal of hepatology.

[98]  D. Eizirik,et al.  TNF-alpha and IFN-gamma potentiate the deleterious effects of IL-1 beta on mouse pancreatic islets mainly via generation of nitric oxide. , 1994, Cytokine.

[99]  S. Bohlander,et al.  Nomenclature of the human interferon genes. , 1994, Journal of interferon research.

[100]  M. Erlander,et al.  Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.

[101]  B. Boucher,et al.  The production of immunoreactive alpha- and gamma-interferon by circulating mononuclear cells in type 1 diabetes. , 1991, Diabetic Medicine.

[102]  R. James,et al.  Cytotoxic effect of IFN-gamma plus TNF-alpha on human islet cells. , 1991, Journal of autoimmunity.

[103]  J. Tuomilehto,et al.  Secular trends in incidence of childhood IDDM in 10 countries. Diabetes Epidemiology Research International Group. , 1990, Diabetes.

[104]  J. Horáček,et al.  [Coxsackie viruses and diabetes mellitus]. , 1978, Sbornik vedeckych praci Lekarske fakulty Karlovy university v Hradci Kralove.

[105]  H. Kremer.  Juvenile diabetes as a sequel to mumps. , 1947, American Journal of Medicine.

[106]  G. Trinchieri,et al.  Interferon / and Interleukin 12 Responses to Viral Infections: Pathways Regulating Dendritic Cell Cytokine Expression In Vivo , 2002 .